Techno Blender
Digitally Yours.
Browsing Tag

Ownership Changes

Hewlett Packard Enterprise Near Deal to Buy Juniper Networks

Updated Jan. 8, 2024 6:31 pm ETHewlett Packard Enterprise is in advanced talks to buy Juniper Networks for about $13 billion, in a bid to better position the nearly 100-year-old technology company in the era of artificial intelligence. A deal between the two companies could be announced as soon as this week, according to people familiar with the matter, assuming the talks don’t fall apart. Copyright ©2024Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Updated Jan. 8, 2024 6:31 pm

Zee Entertainment Shares Fall on Reports of Sony Calling off Merger Deal

Shares of Zee Entertainment Enterprises fell sharply Tuesday after news reports that Japan’s Sony Group may call off a merger of its India operations with the former.Zee Entertainment shares fell as much as 13% and were last down 6.7% at 258.75 Indian rupees ($3.12).Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Shares of Zee Entertainment Enterprises fell sharply Tuesday after news reports that Japan’s SonyGroup may call off a merger of its India operations with

ByteDance in Talks With Potential Buyers to Sell Game Titles

TikTok’s parent company ByteDance is further scaling back its ambitions in the gaming industry and is in talks to sell game titles to several prospective buyers.Chinese media LatePost reported Monday that ByteDance’s gaming unit Nuverse is negotiating to sell games to Tencent. A Bytedance spokesperson told The Wall Street Journal Tuesday that negotiations with multiple potential buyers are ongoing and Nuverse hasn’t finalized any transaction with Tencent.Copyright ©2024Dow Jones & Company, Inc. All Rights Reserved.

GSK Buys Aiolos Bio for Up to $1.4 Bln

Updated Jan. 9, 2024 2:35 am ETGSKsaid it bought biopharmaceutical company Aiolos Bio for an upfront consideration of $1.0 billion and the potential for an additional $400 million, the latest in a string of pharmaceutical majors buying fast-growing biotechs to restock their pipelines.The British pharmaceutical giant said Tuesday that the deal to buy San Francisco and London-based Aiolos Bio, which focuses on patients with respiratory and inflammatory conditions, includes a Phase 2-ready antibody called AIO-001 for the

JetBlue CEO to Step Down as Airline Awaits Judge’s Ruling on Spirit Airlines Merger

Updated Jan. 8, 2024 5:37 pm ETRobin Hayes will step down as CEO of JetBlue Airways after about nine years at the helm, citing a doctor’s advice, as the company waits to find out whether a federal judge will block the merger with Spirit Airlines that he championed. Joanna Geraghty, a longtime JetBlue executive and the airline’s current president, will take his place as chief executive when Hayes steps down in February. She will become the only woman at the helm of a major U.S. airline. Copyright ©2024Dow Jones &

Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2B

Johnson & Johnson will acquire cancer-treatment developer Ambrx Biopharma in a $2 billion cash deal.The pharmaceutical giant said Monday that the deal to acquire all shares of Ambrx for $28 each was expected have a value of $1.9 billion net of estimated cash required.Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Johnson & Johnson will acquire cancer-treatment developer AmbrxBiopharma in a $2 billion cash deal.The pharmaceutical giant said Monday that the

Boston Scientific To Acquire Axonics For About $3.7 Bln

Boston Scientific will acquire Axonics for about $3.7 billion in cash.The companies said on Monday that Axonics had agreed to be bought for $71 a share. Boston Scientific said the deal gave Axonics an equity value of $3.7 billion and an enterprise value of $3.4 billion.Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Boston Scientific will acquire Axonicsfor about $3.7 billion in cash.The companies said on Monday that Axonics had agreed to be bought for $71 a share.

Merck to Buy Harpoon Therapeutics for $680 Million

Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million.Merck on Monday said it will pay $23 a share in cash for Harpoon, more than double Friday’s closing price of $10.55 for the South San Francisco, Calif., company.Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Merck & Co.has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeuticsfor about $680 million.Merck on Monday said

APA to Buy Callon Petroleum in $4.5 Billion Deal

Updated Jan. 4, 2024 7:20 am ETEnergy company APA has agreed to buy smaller peer Callon Petroleum in a stock-swap deal valued at about $4.5 billion including debt, continuing a wave of consolidation in the energy sector.APA on Thursday said it would issue 1.0425 shares, worth $38.31 based on the Wednesday closing price of $36.75, for each share of Callon, offering a nearly 14% premium to Callon’s closing price.Copyright ©2024Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 Updated

Fisker Ditches Tesla-Style Direct-Sales Model in Favor of Dealerships

The electric-vehicle startup Fisker is abandoning a direct-to-consumer sales model in the U.S. in favor of using traditional dealerships, after it found the approach too expensive and struggled in 2023 to get its cars to buyers quickly.The company is in talks with U.S. dealers and hopes to sign up at least 50 this year, said Chief Executive Officer Henrik Fisker. Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 The electric-vehicle startup Fiskeris abandoning a